Fecal Microbiota Transplant (FMT) in pediatric patients with recurrent C. Difficile with or
without Inflammatory Bowel Disease (IBD)
The aims of this study are to determine the safety and efficacy of FMT treatment in pediatric
patients with recurrent or moderate to severe C. Difficile without (through an observational
study) and with (through a clinical trial) Inflammatory Bowel Disease and to determine the
effect of FMT on the gut microbiota through the use of 454 pyrosequencing before and after
transplantation in these patients.